BTG3 and Alzheimer disease: The fact that 37% of the sample had complement activation, 17% had a positive ANA value, 11% had anti-TPO antibodies, and 20% had immunoglobulin abnormalities, taken together with frequent indication of AD in our cohort, is suggestive of immune dysregulation in these individuals.